COPD and triple therapy: When we should and shouldn’t use it – Your questions answered

   Rated 0 / 5 stars

Save

CPD for this activity

Educational Activities (EA)

0.5 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0.5 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0.5 mins

Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0.5 mins

Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.

MO
0 mins

Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.

Listen to the episode

Description

The questions answered in this podcast are listed below. They were compiled by GPs and health professionals around Australia.

  1. How do we go about dignosing COPD?
  2. Do GPs need to refer patients to a respiratory lab?
  3. How to assess patients and if there is an issue?
  4. Are questions that give GPs an idea of progression over time useful?
  5. Would you do bronchial challenge tests in COPD patients to further differentiate who should and shouldn’t get inhaled corticosteroids?
  6. Does vaping increase the risk for COPD?
  7. How do you manage patients with early airflow limitation and symptoms? But who don’t yet meet the criteria for COPD?
  8. Is the treatment of emphysema, the same as for chronic bronchitis?
  9. How can GPs suspect the patient actually has more of a chronic bronchitis issue then a COPD issue?
  10. Is there any role for imaging?
  11. With regard to thyroid function, what are you looking for?
  12. How can you define frequent exacerbations?
  13. What changes in management would you advise with the management of bronchiectasis in the setting of a patient with COPD?
  14. What are the adverse reactions to drugs – Seretide and a risk of pneumonia

Guest: A/Prof Natasha Smallwood, Respiratory Physician

Host: Dr David Lim, GP and Medical Educator

Total time: 41 mins

Last Updated: 10 Oct, 2023

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Fiona Chan

Dr Fiona Chan

Multiple Sclerosis vs Antibody Disease – What GPs Need to Know

Prof Andrew Sindone & Dr Ted Wu

Prof Andrew Sindone & Dr Ted Wu

Using SGLT2 to Reduce Cardiovascular Death in T2D – Important Updates for GPs

Prof Rod Baber

Prof Rod Baber

Menopause and MHT: Maximising Benefits & Minimising Risks

Dr Shannon Thomas

Dr Shannon Thomas

Peripheral Arterial Disease

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

A/Prof Natasha Smallwood

expert

A/Prof Natasha Smallwood

Respiratory Physician, Alfred Hospital; Head of the Chronic Respiratory Disease Research Group, Associate Professor, Monash University

Recent articles

Find your area of interest

Share this

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease